We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GWH:NYSEESS Tech, Inc. Analysis

Data as of 2026-05-22 - not real-time

$0.92

Latest Price

8/10Risk

Risk Level: High

Executive Summary

ESS Tech, Inc. (GWH) is trading at $0.92, well below its 20‑day ($1.00), 50‑day ($1.12) and 200‑day ($1.99) simple moving averages, indicating a pronounced bearish price trend. Technicals show a neutral RSI (42.8) and a bearish MACD histogram, while volatility is extreme at 138% over the past 30 days and beta is modest at 0.59, suggesting price swings are large but not highly correlated with the market. Fundamentally, revenue has collapsed by 78.6% YoY to $128k, operating margins are –107%, and the company carries a debt‑to‑equity ratio of 227, essentially offset by an equal cash balance.
Recent Q1 2026 disclosures highlight aggressive cost cuts that narrowed the net loss, yet earnings per share remain a loss of $0.54 versus consensus expectations. Despite a single analyst’s “strong buy” rating, the combination of negative cash flow, high leverage, and a 52‑week low near $0.56 underscores substantial downside risk, while the current price offers a potentially deep discount to a market that once valued the stock at $13.87.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below all major SMAs and bearish MACD
  • Revenue down 78.6% YoY with negative operating cash flow
  • Extreme short‑term volatility (138% 30‑day) and thin market cap

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Cost‑discipline measures improving loss profile
  • Potential upside if new product line gains traction
  • Valuation still deep‑discounted relative to 52‑week high

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Long‑duration energy storage market growth prospects
  • Low beta indicating limited systematic risk over time
  • Significant upside potential if turnaround succeeds and revenue recovers

Key Metrics & Analysis

Financial Health

Revenue Growth-78.60%
P/E Ratio-1.2
ROE-569.91%
ROA-62.82%
Debt/Equity227.12
P/B Ratio2.4
Op. Cash Flow$-45505000
Free Cash Flow$-29998500
Industry P/E29.5

Technical Analysis

TrendBearish
RSI42.8
Support$0.56
Resistance$1.19
MA 20$1.00
MA 50$1.11
MA 200$1.99
MACDBearish
VolumeIncreasing
Fear & Greed Index91.5

Valuation

Target Price$2.00
Upside/Downside116.94%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.59
Volatility137.75%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.